Consolidated Statements of Changes in Stockholders' Equity (Parentheticals) - At the Market Offering [Member] - USD ($) $ in Billions |
9 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Stock issuance costs | $ 0.7 | $ 0.3 | |
| Pieris Pharmaceuticals, Inc. [Member] | |||
| Stock issuance costs | $ 0.7 | ||
| X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|